MedTrace Logo

Renal Cell Arrest and Damage Biomarkers in Progression and Outcome of Septic AKI

NCT06064487 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2024-06-18

No results posted yet for this study

Summary

The aim of the current study is to assess the predictive value of renal cell arrest biomarkers (urinary TIMP2 and IGFBP7), renal damage biomarkers (urinary KIM-1) and microscopic examination of urinary sediment in progression and outcome of sepsis associated AKI.

Conditions

  • AKI - Acute Kidney Injury

Interventions

DIAGNOSTIC_TEST

renal cell arrest and damage biomarkers assessment

measurement of TIMP2 and IGFBP7, KIM-1

Sponsors & Collaborators

  • Alexandria University

    lead OTHER

Principal Investigators

  • Hala S ElWakil, MD · professor

  • salah s naga, MD · professor

  • Mohamed mamdouh Elsayed, MD · Lecturer

  • Mona m tahoun, MD · Lecturer

  • ahmed E El-deeb, Master · assistant lecturer

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-01
Primary Completion
2024-04-01
Completion
2024-06-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06064487 on ClinicalTrials.gov